TrialEuropean journal of clinical pharmacology2013
Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations.
Ivanka Curkovic et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papertrialcites it